These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7702065)

  • 1. Clotting by heparin of hemoaccess for hemodialysis in an end-stage renal disease patient.
    Pham PT; Miller JM; Demetrion G; Lew SQ
    Am J Kidney Dis; 1995 Apr; 25(4):642-7. PubMed ID: 7702065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis.
    Matsuo T; Yamada T; Chikahira Y; Kadowaki S
    Blut; 1989 Oct; 59(4):393-5. PubMed ID: 2790222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
    Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
    Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: a case report.
    Chan KM; Cheung CY; Chau KF
    Hemodial Int; 2014 Apr; 18(2):555-8. PubMed ID: 24405989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe skin necrosis associated with heparin in hemodialysis.
    Leblanc M; Roy LF; Legault L; Dufresne LR; Morin C; Thuot C
    Nephron; 1994; 68(1):133-7. PubMed ID: 7991024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
    Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
    Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated catheters and heparin-induced thrombocytopenia.
    Laster J; Silver D
    J Vasc Surg; 1988 May; 7(5):667-72. PubMed ID: 3367431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.
    Lim JH; Kang KP; Lee S; Park SK; Kim W
    Hemodial Int; 2017 Apr; 21(2):E30-E33. PubMed ID: 27734602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis, myocardial infarction, and occlusion of vascular access associated with heparin-induced thrombocytopenia in a diabetic hemodialysis patient.
    Igaki N; Matsuda T; Yatani H; Kawaguchi T; Kida A; Yanase K; Moriguchi R; Sakai M; Tamada F; Goto T
    Clin Exp Nephrol; 2003 Dec; 7(4):306-10. PubMed ID: 14712362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro detection of heparin-induced humoral antiplatelet activity.
    Feffer SE; Carmosino LS; Lin JH; Fox RS
    South Med J; 1986 Mar; 79(3):315-8. PubMed ID: 3952542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysis.
    Matsuo T; Chikahira Y; Yamada T; Nakao K; Ueshima S; Matsuo O
    Thromb Res; 1988 Oct; 52(2):165-71. PubMed ID: 3194891
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin-induced immune thrombocytopenia.
    Babcock RB; Dumper CW; Scharfman WB
    N Engl J Med; 1976 Jul; 295(5):237-41. PubMed ID: 945459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-free hemodialysis with a polyacrylonitrile membrane.
    Barth RH; Sodden S; Berlyne GM
    ASAIO Trans; 1989; 35(3):597-600. PubMed ID: 2597544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
    Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
    Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.